HUP9904199A1 - Egyláncú anti-p53 antitest fragmentumok és alkalmazásuk - Google Patents

Egyláncú anti-p53 antitest fragmentumok és alkalmazásuk

Info

Publication number
HUP9904199A1
HUP9904199A1 HU9904199A HUP9904199A HUP9904199A1 HU P9904199 A1 HUP9904199 A1 HU P9904199A1 HU 9904199 A HU9904199 A HU 9904199A HU P9904199 A HUP9904199 A HU P9904199A HU P9904199 A1 HUP9904199 A1 HU P9904199A1
Authority
HU
Hungary
Prior art keywords
subject
antibody fragments
chain antibody
restore
nucleic acids
Prior art date
Application number
HU9904199A
Other languages
English (en)
Inventor
Laurent Bracco
Laurent Debussche
Original Assignee
Rhone-Poulenc Rorer S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone-Poulenc Rorer S.A. filed Critical Rhone-Poulenc Rorer S.A.
Publication of HUP9904199A1 publication Critical patent/HUP9904199A1/hu
Publication of HUP9904199A3 publication Critical patent/HUP9904199A3/hu
Publication of HU226330B1 publication Critical patent/HU226330B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya p53 fehérje elleni egyláncú antitestek, melyekképesek tűmőrős sejtekben kifejeződni, és képesek in vitrőhelyreállítani a DNS-kötő fűnkciót, és in vivő helyreállítani atranszkripciós aktivátőr fűnkciót. A találmány tárgyát képezik azezeket a mőlekűlákat kódőló nűkleinsavak, ezeket tartalmazó vektőrők,és mindezek alkalmazása. Szintén a találmány tárgyát képezik az ilyenantitesteket vagy nűkleinsavakat tartalmazó, hiperprőliferatívrendellenességek kezelésére szőlgáló gyógyszerkészítmények is. ŕ
HU9904199A 1996-10-29 1997-10-27 Anti-p53 single-chain antibody fragments and their uses to produce pharmaceutical compositions HU226330B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9613176A FR2755144B1 (fr) 1996-10-29 1996-10-29 Fragments d'anticorps a chaine unique anti-p53 et utilisation
PCT/FR1997/001921 WO1998018825A1 (fr) 1996-10-29 1997-10-27 Fragments d'anticorps a chaine unique anti-p53 et utilisations

Publications (3)

Publication Number Publication Date
HUP9904199A1 true HUP9904199A1 (hu) 2000-04-28
HUP9904199A3 HUP9904199A3 (en) 2000-09-28
HU226330B1 HU226330B1 (en) 2008-09-29

Family

ID=9497134

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904199A HU226330B1 (en) 1996-10-29 1997-10-27 Anti-p53 single-chain antibody fragments and their uses to produce pharmaceutical compositions

Country Status (21)

Country Link
US (1) US6852509B1 (hu)
EP (1) EP0941252B1 (hu)
JP (1) JP4371178B2 (hu)
KR (1) KR100874789B1 (hu)
AT (1) ATE380198T1 (hu)
AU (1) AU745530B2 (hu)
BR (1) BR9712575A (hu)
CA (1) CA2268865C (hu)
CZ (1) CZ300526B6 (hu)
DE (1) DE69738352T2 (hu)
DK (1) DK0941252T3 (hu)
ES (1) ES2297853T3 (hu)
FR (1) FR2755144B1 (hu)
HU (1) HU226330B1 (hu)
IL (2) IL129476A0 (hu)
NO (1) NO326452B1 (hu)
PT (1) PT941252E (hu)
SI (1) SI0941252T1 (hu)
SK (1) SK286978B6 (hu)
WO (1) WO1998018825A1 (hu)
ZA (1) ZA979738B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121041A0 (en) 1997-06-09 1997-11-20 Yeda Res & Dev Immunogenic compositions for induction of anti-tumor immunity
US7199809B1 (en) 1998-10-19 2007-04-03 Symyx Technologies, Inc. Graphic design of combinatorial material libraries
AU769679B2 (en) * 1999-03-19 2004-01-29 St Vincent's Hospital Sydney Limited Anti-p53 antibodies
AUPP932199A0 (en) * 1999-03-19 1999-04-15 St Vincent's Hospital Sydney Limited Anti-p53 antibodies
DE19962583A1 (de) * 1999-12-23 2001-06-28 Mueller Hermelink Hans Konrad Antikörper gegen Plasmazellen
US6630584B1 (en) * 2000-03-16 2003-10-07 Ramot At Tel-Aviv University Ltd. Single chain antibody against mutant p53
US20080039409A1 (en) * 2003-12-24 2008-02-14 Locomogene, Inc. Method of Suppressing Cancer
JPWO2005061007A1 (ja) * 2003-12-24 2007-07-12 学校法人 聖マリアンナ医科大学 癌の抑制方法
GB0420771D0 (en) * 2004-09-17 2004-10-20 Randox Lab Ltd Antibody
WO2006100681A2 (en) * 2005-03-25 2006-09-28 Ramot At Tel Aviv University Ltd. Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses
WO2007028117A2 (en) * 2005-09-02 2007-03-08 New England Medical Center Hospitals, Inc. P8 as a marker for heart failure
JP7481726B2 (ja) * 2016-05-02 2024-05-13 プロセナ バイオサイエンシーズ リミテッド タウ認識抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224784D0 (en) * 1992-11-26 1993-01-13 Univ Dundee Cellular protein
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel
FR2736915B1 (fr) * 1995-07-19 1997-08-22 Rhone Poulenc Rorer Sa Variants de la proteine p53 et utilisations therapeutiques

Also Published As

Publication number Publication date
NO326452B1 (no) 2008-12-08
DE69738352D1 (de) 2008-01-17
SI0941252T1 (sl) 2008-04-30
ATE380198T1 (de) 2007-12-15
ZA979738B (en) 1998-05-22
HU226330B1 (en) 2008-09-29
KR100874789B1 (ko) 2008-12-18
AU745530B2 (en) 2002-03-21
CZ145599A3 (cs) 1999-08-11
SK55899A3 (en) 2000-06-12
IL129476A (en) 2010-05-17
JP4371178B2 (ja) 2009-11-25
AU4952097A (en) 1998-05-22
DK0941252T3 (da) 2008-03-31
CA2268865C (fr) 2011-01-04
WO1998018825A1 (fr) 1998-05-07
JP2001502553A (ja) 2001-02-27
ES2297853T3 (es) 2008-05-01
BR9712575A (pt) 1999-10-19
CA2268865A1 (fr) 1998-05-07
SK286978B6 (sk) 2009-08-06
FR2755144A1 (fr) 1998-04-30
NO991729L (no) 1999-04-13
US6852509B1 (en) 2005-02-08
IL129476A0 (en) 2000-02-29
NO991729D0 (no) 1999-04-13
HUP9904199A3 (en) 2000-09-28
KR20000052845A (ko) 2000-08-25
FR2755144B1 (fr) 1998-11-27
EP0941252A1 (fr) 1999-09-15
PT941252E (pt) 2008-03-07
DE69738352T2 (de) 2008-11-13
EP0941252B1 (fr) 2007-12-05
CZ300526B6 (cs) 2009-06-10

Similar Documents

Publication Publication Date Title
HUP9904199A1 (hu) Egyláncú anti-p53 antitest fragmentumok és alkalmazásuk
HUP0105058A2 (hu) Perifériás benzodiazepin receptorhoz kötődő anyag alkalmazása kutánstressz kezelésére
HUP0105303A2 (en) Her-2/neu fusion proteins
HUP0003533A2 (hu) Interleukin-18-at kötő fehérjék, előállításuk és alkalmazásuk
EP1067182A3 (en) Secretory protein or membrane protein
NO306725B1 (no) Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler
HUP0202512A2 (hu) Fehérjék polimerizációját gátló anyagok és eljárások ezek alkalmazására
BR0009505A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
HUP0102005A2 (hu) CD23 elleni antitestek, ezek származékai, és gyógyászati alkalmazásuk
DE3856180D1 (de) Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
WO2000015826A3 (en) Leptin induced genes
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
DE69822307D1 (de) Menschliches adamts-1 protein, gen , welches für dieses kodiert, pharmazeutische zusammensetzung und verfahrem zur immunologischen bestimmung von menschlichen adamts-1 proteinen
HUP9901343A2 (hu) P53 protein variánsok és gyógyászati felhasználásuk
BR9509172A (pt) Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica
NL190399B (nl) Ijzer-bevattend eiwitmateriaal, bereiding daarvan, en farmaceutisch preparaat voor de behandeling van sideropene anaemie.
EP0350690A3 (de) Neutralisation der in vitro- und in vivo-toxischen Eigenschaften von TNF-alfa durch monoklonale Antikörper und die davon abgeleiteten Fragmente
WO1995011975A3 (en) Retroviral superantigens, superantigen peptides, and methods of use
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
DK0382076T3 (da) Phenylhydrazoner, fremgangsmåde til fremstilling heraf og lægemidler og kosmetika fremstillet heraf
BR9712767A (pt) Expressão especìfica para tecido de proteìna de retinoblastoma
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
ATE230027T1 (de) Menschliche dnase i varianten
WO2001040271A3 (en) Cancer associated antigens and uses therefor
ATE223227T1 (de) Verwendung von lbp zur sepsistherapie

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): DR. LANG TIVADARNE, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU

Representative=s name: DANUBIA SZABADALMI ES JOGI IRODA KFT., HU

FH92 Termination of representative

Representative=s name: DR. LANG TIVADARNE, S.B.G. & K. SZABADALMI UEG, HU

MM4A Lapse of definitive patent protection due to non-payment of fees